Glymphatic function associates with Alzheimer’s disease—signature region volumes, plasma biomarkers and white matter hyperintensity progression in cognitively unimpaired older adults
Age and Ageing · 31.05.2025 · 54 (6)
DOI: 10.1093/ageing/afaf141 ↗Kurz gefasst
Fachartikel in der Zeitschrift Age and Ageing, online erschienen am 03.06.2025. Verfasst von Qian Chen und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Alzheimer Disease, White Matter, Glymphatic System, Cognition. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Clinical Trials from the Affiliated Drum Tower Hospital, Medical School of Nanjing University, National Science and Technology Innovation 2030-Major program of 'Brain Science and Brain-Like Research', General Project Supported by Medical Science and technology development Foundation, Nanjing Department of Health.
Themen: Gerontologische Pflege, Demenz
Abstract (Originalsprache)
Background
Brain glymphatic system is thought to play a critical role in the pathogenesis of Alzheimer’s disease (AD).
Objective
To investigate the relationships between glymphatic function and AD-signature region volumes, plasma biomarkers and disease progression in cognitively unimpaired older adults.
Methods
Two datasets comprising a total of 229 cognitively unimpaired older adults were enrolled. Brain glymphatic function was assessed using diffusion tensor imaging along the perivascular space (DTI-ALPS). The associations between the DTI-ALPS index and volumes in AD-signature regions, including the basal forebrain, entorhinal cortex and hippocampus, were evaluated, along with white matter hyperintensity (WMH) volumes. In dataset 1 with plasma biomarkers, the mediation effects of DTI-ALPS index on plasma biomarkers and cognition were examined. In dataset 2 with follow-up data, the baseline DTI-ALPS index was correlated with the annual percent change in volumes of AD-signature regions and WMH.
Results
The DTI-ALPS index showed positive correlations with volumes in the basal forebrain, entorhinal cortex and hippocampus, and negative correlations with WMH volumes in both datasets. The DTI-ALPS index negatively associated with plasma phosphorylated tau (ptau) and mediated the relationship between ptau and cognition. The baseline DTI-ALPS index was negatively associated with WMH progression at follow-up.
Conclusion
Worse glymphatic system function indicates decreased AD-signature region volumes, severe WMH lesions, elevated plasma ptau, and accelerated WMH progression before the occurrence of objective cognitive impairment. Therapeutic methods targeting the glymphatic system may prevent cognitive decline through the clearance of AD pathological proteins and the deceleration of WMH lesions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China.
- Department of Radiology, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, China.
- Department of Psychology, Nanjing University, Nanjing, China.
- Institute of Medical Imaging and Artificial Intelligence, Nanjing University, Nanjing, China.
- Medical Imaging Center, Department of Radiology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
Förderung
- Clinical Trials from the Affiliated Drum Tower Hospital, Medical School of Nanjing University
- National Science and Technology Innovation 2030-Major program of 'Brain Science and Brain-Like Research'
- General Project Supported by Medical Science and technology development Foundation, Nanjing Department of Health
- National Natural Science Foundation of China
- National Science and Technology Innovation 2030—Major program of ‘Brain Science and Brain-Like Research’
Zitieren
APA
Chen, Q., Ge, D., Xu, X., Chen, F., Du, S., Bai, Y., Liu, D., Lei, Y., Zhu, Y., Long, C., Lu, J., Lv, P., Zhang, X., & Zhang, B. (2025). Glymphatic function associates with Alzheimer’s disease—signature region volumes, plasma biomarkers and white matter hyperintensity progression in cognitively unimpaired older adults. Age and Ageing, 54(6). https://doi.org/10.1093/ageing/afaf141
Vancouver
Chen Q, Ge D, Xu X, Chen F, Du S, Bai Y, et al. Glymphatic function associates with Alzheimer’s disease—signature region volumes, plasma biomarkers and white matter hyperintensity progression in cognitively unimpaired older adults. Age and Ageing. 2025;54(6). doi:10.1093/ageing/afaf141
BibTeX
@article{Chen2025,
author = {Chen, Qian and Ge, Danni and Xu, Xinru and Chen, Futao and Du, Shunshun and Bai, Yijun and Liu, Dongming and Lei, Yan and Zhu, Yajing and Long, Cong and Lu, Jiaming and Lv, Pin and Zhang, Xin and Zhang, Bing},
title = {Glymphatic function associates with Alzheimer’s disease—signature region volumes, plasma biomarkers and white matter hyperintensity progression in cognitively unimpaired older adults},
journal = {Age and Ageing},
year = {2025},
volume = {54},
number = {6},
doi = {10.1093/ageing/afaf141}
}
EUVIMED